Rundown on meningococcal disease
Invasive meningococcal disease is increasing in Australia, with serogroup W now predominating.1
The introduction in Australia in 2003 of the meningococcal serogroup C (MenC) vaccine has been an unqualified success.
Between 2002 and 2016, cases of MenC dropped by 99%. There was an associated overall decrease in invasive meningococcal disease by 82% between 2002 and 2013. Over this period, meningococcal serogroup B (MenB) replaced MenC as the predominant strain of meningococcus in Australia.1
However, since 2014